NPM1 and acute myeloid leukemia: To further confirm the hypothesis that efficient responses against immunogenic NPM1-mutated epitopes may be induced in humans, Kuzelova et al., identified a skewed HLA molecule distribution in AML patients and documented that subjects expressing HLA alleles suitable for actively presenting NPM1-derived peptides are less prone to develop NPM1-mutated AML [18].